A coagulation factor IX-deficient mouse model for human hemophilia B

Blood

Volumn 90, Issue 10, 1997, Pages 3962-3966

  Lin, Hui Feng ^a   Maeda, Nobuyo ^a   Smithies, Oliver ^a   Straight, David L ^a   Stafford, Darrel W ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA DETERMINATION; DOG; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE THERAPY; HEMOPHILIA B; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030817391     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.3962     Document Type: Article

References (22)

1. Giannelli F, Green PM, Sommer SS, Poon M-C, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG: Hemophilia B: Database of point mutations and short additions and deletions, 7th edition. Nucleic Acids Res 25:133, 1997
2. Thompson AR, Chen SH: Characterization of factor IX defects in hemophilia B patients. Methods Enzymol 222:143, 1993
3. Brinkhous KM: Gene transfer in the hemophilias: Retrospect and prospect. Thromb Res 67:329, 1992
4. Lozier JN, High KA: Molecular basis of hemophilia. Hematol Pathol 4:1, 1990
5. Kurachi K, Furukawa M, Yao SN, Kurachi S: Biology of factor IX. Hematol Oncol Clin North Am 6:991, 1992
6. Larson PJ, High KA: Biology of inherited coagulopathies: Factor IX. Hematol Oncol Clin North Am 6:999, 1992
7. Brinkhous KM, Hedner U, Garris JB, Diness V, Read MS: Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease. Proc Natl Acad Sci USA 86:1382, 1989
8. Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM: In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX-deficient dogs. Science 262:117, 1993
9. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR: In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91:2353, 1994
10. St Louis D, Verma IM: An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci USA 85:3150, 1988
11. Yao SN, Kurachi K: Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc Natl Acad Sci USA 89:3357, 1992
12. Yao SN, Smith KJ, Kurachi K: Primary myoblast-mediated gene transfer: Persistent expression of human factor IX in mice. Gene Ther 1:99, 1994
13. Walter J, You Q, Hagstrom JN, Sands M, High KA: Successful expression of human factor IX following repeat administration of adenoviral vector in mice. Proc Natl Acad Sci USA 93:3056, 1996
14. Cheung WF, Hamaguchi N, Smith KJ, Stafford DW: The binding of human factor IX to endothelial cells is mediated by residues 3-11. J Biol Chem 267:20529, 1992
15. Detloff PJ, Lewis J, John SW, Shehee WR, Langenbach R, Maeda N, Smithies O: Deletion and replacement of the mouse adult beta-globin genes by a "plug and socket" repeated targeting strategy. Mol Cell Biol 14:6936, 1994
16. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC: Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153, 1991
17. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
18. Wu SM, Stafford DW, Ware J: Deduced amino acid sequence of mouse blood-coagulation factor IX. Gene 86:275, 1990
19. Pang CP, Crossley M, Kent G, Brownlee GG: Comparative sequence analysis of mammalian factor IX promoters. Nucleic Acids Res 18:6731, 1990
20. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K: Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 24:3736, 1985
21. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH, Jr: Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 10:119, 1995
22. Bi L, Sarkar R, Naas T, Lawler AM, Pain J, Shumaker SL, Bedian V, Kazazian HH Jr: Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 88:3446, 1996